 Sydney, Aug. 31, 2021 GLOBE NEWSWIRE -- SYDNEY, AUSTRALIA 31 August 2021 Immutep Limited ASX: IMM; NASDAQ: IMMP Immutep or the Company is pleased to advise its Chinese partner for eftilagimod alpha efti or IMP321, EOC Pharma EOC is planning to expand its clinical trial pipeline for efti designated EOC202 in China in China. 